S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag

Balchem (BCPC) Stock Forecast, Price & News

$132.82
+7.45 (+5.94%)
(As of 06/2/2023 ET)
Compare
Today's Range
$127.10
$133.07
50-Day Range
$122.28
$132.82
52-Week Range
$110.15
$143.88
Volume
78,021 shs
Average Volume
84,957 shs
Market Capitalization
$4.28 billion
P/E Ratio
43.41
Dividend Yield
0.53%
Price Target
$140.00

Balchem MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.4% Upside
$140.00 Price Target
Short Interest
Healthy
0.97% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.54
Upright™ Environmental Score
News Sentiment
1.56mentions of Balchem in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$680,858 Sold Last Quarter
Proj. Earnings Growth
20.00%
From $3.60 to $4.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Basic Materials Sector

41st out of 163 stocks

Chemicals & Allied Products Industry

7th out of 16 stocks


BCPC stock logo

About Balchem (NASDAQ:BCPC) Stock

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Stock News Headlines

StockNews.com Initiates Coverage on Balchem (NASDAQ:BCPC)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Balchem: A Mixed Quarter
Q1 2023 Balchem Corp Earnings Call
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Balchem (BCPC) Set to Announce Earnings on Friday
Balchem Co. (NASDAQ:BCPC) Director Sells $381,030.00 in Stock
Balchem Full Year 2022 Earnings: EPS Misses Expectations
Q4 2022 Balchem Corp Earnings Call
See More Headlines

BCPC Price History

BCPC Company Calendar

Last Earnings
4/28/2023
Today
6/03/2023
Next Earnings (Estimated)
8/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,340
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$140.00
High Stock Price Forecast
$140.00
Low Stock Price Forecast
$140.00
Forecasted Upside/Downside
+5.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$105.37 million
Pretax Margin
13.24%

Debt

Sales & Book Value

Annual Sales
$942.36 million
Cash Flow
$5.18 per share
Book Value
$30.20 per share

Miscellaneous

Free Float
31,712,000
Market Cap
$4.28 billion
Optionable
Optionable
Beta
0.70

Social Links


Key Executives

  • Theodore L. Harris
    Chairman, President & Chief Executive Officer
  • Martin Bengtsson
    Chief Financial Officer & Executive VP
  • Michael Sestrick
    Chief Technology Officer & Senior Vice President
  • Hatsuki Miyata
    Secretary, Executive VP & General Counsel
  • Brent Tignor
    Chief Human Resources Officer & Senior VP













BCPC Stock - Frequently Asked Questions

Should I buy or sell Balchem stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings
or view top-rated stocks.

What is Balchem's stock price forecast for 2023?

1 equities research analysts have issued 1 year price objectives for Balchem's shares. Their BCPC share price forecasts range from $140.00 to $140.00. On average, they predict the company's share price to reach $140.00 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price.
View analysts price targets for BCPC
or view top-rated stocks among Wall Street analysts.

How have BCPC shares performed in 2023?

Balchem's stock was trading at $122.11 on January 1st, 2023. Since then, BCPC stock has increased by 8.8% and is now trading at $132.82.
View the best growth stocks for 2023 here
.

Are investors shorting Balchem?

Balchem saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 309,900 shares, a decline of 7.4% from the April 30th total of 334,700 shares. Based on an average daily volume of 89,200 shares, the short-interest ratio is presently 3.5 days. Currently, 1.0% of the company's stock are short sold.
View Balchem's Short Interest
.

When is Balchem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our BCPC earnings forecast
.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings results on Friday, April, 28th. The basic materials company reported $0.70 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.78 by $0.08. The basic materials company earned $232.54 million during the quarter, compared to analysts' expectations of $232 million. Balchem had a net margin of 10.48% and a trailing twelve-month return on equity of 10.69%. During the same period in the prior year, the firm posted $0.89 EPS.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Tuesday, December 6th. Investors of record on Tuesday, December 27th will be paid a dividend of $0.71 per share on Friday, January 20th. This represents a yield of 0.53%. The ex-dividend date of this dividend is Friday, December 23rd. This is a boost from the stock's previous annual dividend of $0.64.
Read our dividend analysis for BCPC
.

Is Balchem a good dividend stock?

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.57%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 16.44% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.22%), Wasatch Advisors LP (6.42%), State Street Corp (3.37%), Conestoga Capital Advisors LLC (3.26%), Dimensional Fund Advisors LP (2.05%) and Geode Capital Management LLC (2.04%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Michael Robert Sestrick, Scott C Mason and William A Backus.
View institutional ownership trends
.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $132.82.

How much money does Balchem make?

Balchem (NASDAQ:BCPC) has a market capitalization of $4.28 billion and generates $942.36 million in revenue each year. The basic materials company earns $105.37 million in net income (profit) each year or $3.06 on an earnings per share basis.

How many employees does Balchem have?

The company employs 1,340 workers across the globe.

Does Balchem have any subsidiaries?
The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..
Read More
How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717.

This page (NASDAQ:BCPC) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -